2024-09-26
On the afternoon of September 24
The Productivity Centre of Jiangsu Province
announced the results of the 2024 evaluations for Jiangsu Unicorn Companies and Gazelle Companies.
Suzhou Singular Medical Device Co., Ltd.
has been selected as a Potential Unicorn Company in Jiangsu
for four consecutive years.
Singular Medical is a leading innovator in the independent development and manufacturing of CRM devices in China, committed to creating high-end CRM solutions for Chinese patients. Its product portfolio includes ICDs, ICMs, CSP systems, and external heart failure monitoring devices. Singular Medical has built an elite team of experienced engineers and industry experts dedicated to delivering high-quality, accessible medical products and services to benefit more patients.
The domestically developed ICD—Ambow® by Singular Medical has broken through technological barriers and has completed the full enrollment for its clinical trial. This product is fully protected by intellectual property rights, offering features such as automatic pacing detection, 40J energy charge and discharge, SVT discrimination, streamlined design, and Bluetooth telemetry. Its performance rivals that of leading imported products, and it has entered the National Medical Products Administration's special approval process for innovative products (green channel).
This ICM is a product with complete intellectual property rights independently developed by the company. It is capable of accurately detecting a variety of arrhythmia signals and features a large ECG storage capacity. As the first ICM in China, it uses a titanium alloy body, offering excellent biocompatibility. The product not only breaks through the technical barriers of traditional ICMs and covers home-based monitoring, but it also leads the way by incorporating Bluetooth telemetry, supporting real-time mobile-to-cloud data transmission, and providing more timely diagnostic assistance. The ICM has successfully completed model testing and animal experiments, and it has entered the National Medical Products Administration innovation product special review process (green channel). Recently, it has completed all patient enrollment and follow-up in clinical trials.
In 2022, Singular Medical was named "Best Medical Technology Company in China 2022" by Medtech Outlook magazine. In 2023, the company was included in the "Forbes Asia 100 Companies to Watch" list, earning international recognition for its professional capabilities. In May 2024, the company’s ICD product was listed on the "VBEF 2024 Annual Innovation Products in Healthcare and Medical Industry" list, with the industry fully acknowledging the company's outstanding contributions and remarkable achievements in the medical field.
Looking ahead, Singular Medical will continue to uphold innovation, quality, and service as its core values, adhering to a "patient-centered" philosophy. The company will consistently enhance its technological and service capabilities, expand its CRM product portfolio to meet clinical needs, and make outstanding contributions to global healthcare.
Company Introduction
Suzhou Singular Medical Co., Ltd. is a high-tech company focused on the development and industrialization of medical devices for Cardiac Rhythm Management (CRM).
The company's headquarters are located in the Medical Device Industrial Park within the High-Tech Zone of Suzhou, with a 2,800 square meter manufacturing facility. Singular Medical also has research and development centers in Beijing, Irvine (USA), and Minnesota (USA). Starting with the most technically challenging product in the CRM field, the Implantable Cardiac Defibrillator (ICD), Singular Medical has built a comprehensive CRM technology platform. The company is growing to become a supplier of a full range of CRM products in China, capable of providing a complete solution for patients with cardiac arrhythmias, ranging from monitoring and diagnosis to treatment and postoperative follow-up.
[Click to view the original text]
